Relapsing Remitting Multiple Sclerosis Patients Initiated on Oral DMF Report a Better Quality of Life Compared to Patients on Platform Therapies as Measured by Eq-5d

Value in Health - United Kingdom
doi 10.1016/j.jval.2015.09.2492
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search